
    
      275 post menopausal women are treated with either 750 mg strontium malonate, 1000 mg
      strontium malonate, 2000 mg strontium malonate, 2 g ProtelosÂ® or placebo.

      Patients are treated for 12 weeks. A follow up period of 4 weeks is planned for the main
      study and a follow up period of 8 weeks is planned for approximately 20% of the patients to
      follow post treatment CTX-1 activity.

      Apart from S-CTS-1 also response on other bio markers are evaluated as well as BMD.
    
  